🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Nephrotic syndrome (NS) is a clinical picture common to several diseases re...
Status
Unknown
Location
Meyer Children's Hospital IRCCS
Start Date
2022-01-26
Trial ID
NCT06325098
Treatments Being Tested
RATIONALE: Panobinostat and imatinib mesylate may stop the growth of cancer...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-05
Trial ID
NCT00686218
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00899002
The objective of this study is to determine the prevalence and transmission...
Status
Completed
Location
SickKids - The Hospital for Sick Children
Start Date
2020-10-06
Trial ID
NCT05234359
Treatments Being Tested
RATIONALE: Diagnostic procedures that analyze surgically-removed tumor tiss...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
2002-09
Trial ID
NCT00049010
The purpose of this study is to analyze biopsied tissue samples for changes...
Status
Active Not Recruiting
Location
The Guthrie Clinic
Start Date
2017-11-15
Trial ID
NCT03316053
Treatments Being Tested
In this large-scale cross-sectional study, we evaluated disease-free surviv...
Status
Completed
Location
Multiple Locations
Start Date
1991-04
Trial ID
NCT05754047
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
City of Hope Medical Center
Start Date
2011-10-03
Trial ID
NCT01267812
RATIONALE: Studying the proteins expressed in samples of blood and tissue f...
Status
Unknown
Location
Istituto Scientifico H. San Raffaele
Start Date
2008-02
Trial ID
NCT00989690
The purpose of the study is to evaluate if firefighter exposure to hazardou...
Status
Recruiting
Location
Levine Cancer Institute
Start Date
2026-06-23
Trial ID
NCT06870760